• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Admin

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Oct 13
8:00 am - 9:00 am EDT

Member Forum: Technology Solutions for PALS

Oct 13
6:00 pm - 7:00 pm EDT

Member Forum: Technology Solutions for PALS

Oct 15
9:00 am - 10:00 am EDT

Webinar: The Use of AI in ALS/MND

Oct 17
2:00 pm - 3:00 pm EDT

ALS Association Webinar: So, What’s Next? Understanding the Decisions along an ALS Journey

Oct 21
7:00 am - 8:30 am EDT

Member Roundtable: Defining Rights in the Genetics Era of ALS/MND

View Calendar

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Michael Lee, Australia

    Michael Lee, Australia

  • Jon Newsome, USA

    Jon Newsome, USA

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Jack Buzby, USA

    Jack Buzby, USA

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Len Johnrose, England

    Len Johnrose, England

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Sally Pauls, USA

    Sally Pauls, USA

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • David Watson, Scotland

    David Watson, Scotland

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Glen Elison, USA

    Glen Elison, USA

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Bob Simonds, USA

    Bob Simonds, USA

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Paul Launer, USA

    Paul Launer, USA

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Christian Bär, Germany

    Christian Bär, Germany

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Ali Var, Turkey

    Ali Var, Turkey

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Lombana, Spain

    Lombana, Spain

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Susan Anderson, USA

    Susan Anderson, USA

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Mike Small, UK

    Mike Small, UK

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login